Our Managing Director Robert Tucci attended the MedTech Innovator East Coast Pitch Event in Washington DC earlier this month. #medtech #lifesciences #vcfunding #startups #startup #earlystage #earlystageinvesting #pitchcompetition
关于我们
Texas HALO Fund is an investment company specializing in diverse, early stage businesses with promising growth prospects and exceptional management teams. Our investment approach identifies compelling businesses from multiple sources without regard to industry or geographic location. Quite simply, we seek the best opportunities, locally, regionally and nationally, in order to generate the highest returns for our investors with the lowest possible risk. Each fund invests in multiple companies in a variety of industries in order to construct a diversified portfolio. Our process involves rigorous due diligence and extensive interaction with management prior to making a capital commitment and then active on-going oversight, often through board positions or board observation rights. Texas HALO Fund was created to give investors access to the high return potential of early-stage investments while addressing the unique challenges that confront investors attempting to create a diversified portfolio, such as quality deal flow, due diligence expertise, and limited capital to spread among the many investments needed in a diversified portfolio.
- 网站
-
https://www.texashalofund.com/
Texas HALO Fund的外部链接
- 所属行业
- 投资管理
- 规模
- 2-10 人
- 总部
- Houston,Texas
- 类型
- 私人持股
- 创立
- 2012
- 领域
- venture capital
地点
-
主要
2726 Bissonnet St.
#240-425
US,Texas,Houston,77005
Texas HALO Fund员工
动态
-
Our portfolio company VenoStent, Inc., a clinical stage therapeutic medical device company developing wraps to improve the outcomes of dialysis patients has enrolled its first subjects in its US based clinical trial. #earlystageinvesting #vc #venturecapital #medicaldevices #clinicaltrial #dialysis #investing #startup